Epanutin and Carbagen are epilepsy drugs named on Gov’s ‘short supply’ list
19 November 2019
A 24-page document circulated to doctors by the Department of Health and Social Care (DHSC) last week, lists many drugs which are currently in short supply, including...
All strengths of Gabitril (tiagabine) are now back in stock
15 November 2019
Teva UK has confirmed that all strengths of Gabitril (5mg, 10mg, 15mg) are now back in stock and that these have been made available to pharmacies across the country...
Epanutin (phenytoin) Infatabs 50 mg still out of stock
5 November 2019
We have been advised by the pharmaceutical company Pfizer that due to manufacturing delays, Epanutin (phenytoin) Infatabs 50mg are still out of stock.
Valproate and pregnancy awareness survey 2019
24 October 2019
Are you a woman or girl under the age of 55 who is taking, or has taken, sodium valproate since 1 August 2018? We want to find out how much women and girls of...
Gabitril (tiagabine) 10mg should be available next week, says Teva UK
21 October 2019
We have been informed by Teva UK that Gabitril (tiagabine) 10mg strength should be available in pharmacies from the middle of next week.
New identity document for voters
16 October 2019
People with hidden disabilities such as epilepsy, will not be penalized by new Government plans to introduce compulsory photo ID cards for voters before a general...
Plans for medicines supplies post Brexit are in good shape, says Government
10 October 2019
Epilepsy Society has welcomed the news that 96 per cent of medicine suppliers in the UK have now responded to the Government about their preparations for exiting the...
Epilepsy Society responds to risks around medication shortages
8 October 2019
On 7 October 2019, The Mirror published an article about the risks surrounding medication shortages. Here is the full quote that we sent to them.
Epilepsy Society welcomes European approval of medicinal cannabis for severe childhood epilepsies
23 September 2019
Epilepsy Society's medical director Professor Ley Sander has cautiously welcomed a decision by the European Commission to approve Epidyolex in the treatment of two...